RxDoctor Payments Data

Luis Lopez Perez, MD

Family Medicine · Manati, PRNPI 1477025591

Payments from drug & device makers

$1,275in general payments, 2019–2025

Across 42 payments — averaging $30.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$591
  • E.r. Squibb & Sons, L.L.C.$210
  • AbbVie$182
  • AstraZeneca$157
  • Novartis$43
  • PBG Puerto Rico LLC$39
  • plus $52 from 4 others

What the payments were for

  • Food & beverage$1,275100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,275 in reported general payments places this provider in the 85th percentile of 497 family medicine providers in Puerto Rico.

See all family medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$10,147
Medicare patients
13
Services billed
85

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban22$12,591
EliquisApixaban20$11,958
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav63$1,064
Famotidine62$405
Levofloxacin50$361
Sucralfate14$341
Montelukast Sodium39$300
Atorvastatin Calcium49$289
Cefdinir18$267
Losartan Potassium43$254
Furosemide51$225
ClopidogrelClopidogrel Bisulfate28$165
Tamsulosin Hcl23$162
Lisinopril19$149
Methylprednisolone15$144

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$591$12,59122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 497 family medicine providers in Puerto Rico.

Other family medicine in Manati

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →